Exelixis | DEBITO



Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Bayer EUR 40.7B 465M 2024-12
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Cytokinetics USD 657.12M 1.1M 2024-12
Eisai JPY 219.1B 36.2B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 0 0 2025-01
Genmab DKK 1.03B 42M 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Sanofi 17.91B 5.85B 2024-12
Takeda JPY 4.84T 211.04B 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Xencor USD 163.61M 145.69M 2024-12



Exelixis DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.